Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May;18(5):374-377.
doi: 10.1200/OP.22.00096.

Challenges in Genetic Testing and Treatment Outcomes Among Hispanics With Lung Cancer

Luis E Raez  1 , Andrés F Cardona  2 , Gilberto Lopes  3 , Oscar Arrieta  4
Affiliations
Editorial

Challenges in Genetic Testing and Treatment Outcomes Among Hispanics With Lung Cancer

Luis E Raez et al. JCO Oncol Pract. 2022 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Luis E. RaezResearch Funding: Genentech/Roche (Inst), Merck Serono (Inst), Boehringer Ingelheim (Inst), Novartis (Inst), Pfizer (Inst), Syndax (Inst), Loxo (Inst), Merck (Inst), Bristol Myers Squibb (Inst), Guardant Health (Inst), Heat Biologics (Inst), Amgen (Inst), Calithera Biosciences (Inst), Daiichi Sankyo/UCB Japan (Inst), NantHealth (Inst) Andrés F. CardonaHonoraria: Bristol Myers Squibb, Roche, Boehringer Ingelheim, AbbVie, Merck Sharp & Dohme, CelldexConsulting or Advisory Role: Roche, Merck Sharp & Dohme, Novartis, AstraZeneca, Bristol Myers Squibb, Foundation Medicine, Boehringer Ingelheim, Foundation for Clinical and Applied Cancer Research (FICMAC)Speakers' Bureau: Merck Sharp & Dohme, Roche, Bristol Myers Squibb, Novartis, Foundation for Clinical and Applied Cancer Research (FICMAC), Foundation MedicineTravel, Accommodations, Expenses: Merck Sharp & Dohme, Bristol Myers Squibb, Roche, Boehringer Ingelheim, Foundation Medicine Gilberto LopesStock and Other Ownership Interests: Lucence Diagnostics, XilisHonoraria: Boehringer Ingelheim, Blueprint Medicines, AstraZeneca, MerckConsulting or Advisory Role: Pfizer, AstraZenecaResearch Funding: Merck Sharp & Dohme (Inst), EMD Serono (Inst), AstraZeneca (Inst), AstraZeneca, Blueprint Medicines (Inst), Tesaro (Inst), Bavarian Nordic (Inst), Novartis (Inst), G1 Therapeutics (Inst), Adaptimmune (Inst), BMS (Inst), GlaxoSmithKline (Inst), AbbVie (Inst), Rgenix (Inst), Pfizer (Inst), Roche (Inst), Genentech (Inst), Lilly (Inst), Janssen (Inst), Lucence, Lucence, Xilis, E.R. Squibb Sons, LLCTravel, Accommodations, Expenses: Boehringer Ingelheim, Pfizer, E.R. Squibb Sons, LLC, Janssen, Seattle Genetics, Celgene, Ipsen, Pharmacyclics, Merck, AstraZenecaOther Relationship: Mirati Therapeutics Oscar ArrietaHonoraria: Pfizer, AstraZeneca, Boehringer Ingelheim, RocheConsulting or Advisory Role: AstraZeneca, Roche, Lilly, Merck, Bristol Myers SquibbResearch Funding: Roche (Inst), BMS (Inst), Merck (Inst), AstraZeneca (Inst)Travel, Accommodations, Expenses: LillyNo other potential conflicts of interest were reported.

Publication types

LinkOut - more resources